Amylyx Pharmaceuticals (AMLX) Change in Inventory (2022 - 2024)

Amylyx Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $9.3 million for Q1 2024.

• On a quarterly basis, Change in Inventory fell 30.44% year-over-year to $9.3 million in Q1 2024; TTM through Dec 2024 was $9.3 million, a 87.35% decrease from a year earlier, with the FY2024 full-year figure at $9.3 million, down 87.35% from the prior year.
• Change in Inventory declined to $9.3 million in Q1 2024 per AMLX's latest filing, from $26.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $26.5 million in Q4 2023 and bottomed at $9.2 million in Q4 2022.
• The 3-year median for Change in Inventory is $13.7 million (2023), against an average of $15.3 million.
• Across the five-year window, Change in Inventory soared 187.65% in 2023 and slumped 30.44% in 2024, its largest moves.
• Year by year, Change in Inventory stood at $9.2 million in 2022, then surged by 187.65% to $26.5 million in 2023, then slumped by 65.06% to $9.3 million in 2024.
• Per Business Quant, the three latest AMLX Change in Inventory figures stand at $9.3 million (Q1 2024), $26.5 million (Q4 2023), and $14.0 million (Q3 2023).